COVID-19HealthcareNewsSectors

Remdesivir Injection’s Price Reduced, Here are the New Prices

Sharing is caring!

National Pharmaceutical Pricing Authority said major Pharma companies have announced voluntary price cuts for Remdesivir Injections after Centre’s intervention to ensure it’s affordable availability. Cadila Healthcare’s Remdac will now cost 899 rupees instead of Rupees 2800.

Syngene International’s RemWin will now cost 2 thousand 450 rupees instead of 3 thousand 950 rupees. Dr Reddy’s Redyx will be available at 2 thousand 700 rupees instead of 5 thousand 400 rupees. Cipla’s Cipremi will cost 3 thousand rupees instead of 4 thousand rupees. Mylan Pharmaceutical’s Desrem will be available at 3 thousand 400 rupees instead of 4 thousand 800 rupees. Jubilant Generic’s Jubi-R will now cost 3 thousand 400 rupees instead of 4 thousand 700 rupees. Hetero Healthcare’s Covifor will be available at 3 thousand 490 rupees instead of 5 thousand 400 rupees.

Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body. (Ref: Mediline Plus)

SMEStreet Edit Desk

SMEStreet Edit Desk is a small group of excited and motivated journalists and editors who are committed to building MSME ecosystem through valuable information and knowledge spread.

Related Articles

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
%d bloggers like this: